308 related articles for article (PubMed ID: 21571054)
1. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
2. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
Seguin J; Brullé L; Boyer R; Lu YM; Ramos Romano M; Touil YS; Scherman D; Bessodes M; Mignet N; Chabot GG
Int J Pharm; 2013 Feb; 444(1-2):146-54. PubMed ID: 23380621
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
Ragelle H; Crauste-Manciet S; Seguin J; Brossard D; Scherman D; Arnaud P; Chabot GG
Int J Pharm; 2012 May; 427(2):452-9. PubMed ID: 22387278
[TBL] [Abstract][Full Text] [Related]
4. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo.
Zalba S; Navarro I; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2012 Jun; 81(2):273-80. PubMed ID: 22369879
[TBL] [Abstract][Full Text] [Related]
5. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study.
Bothiraja C; Yojana BD; Pawar AP; Shaikh KS; Thorat UH
Expert Opin Drug Deliv; 2014 Jan; 11(1):17-29. PubMed ID: 24294925
[TBL] [Abstract][Full Text] [Related]
6. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
7. In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein.
Wang T; Kulkarni N; Bedi D; D'Souza GG; Papahadjopoulos-Sternberg B; Petrenko VA; Torchilin VP
J Drug Target; 2011 Sep; 19(8):597-605. PubMed ID: 21275826
[TBL] [Abstract][Full Text] [Related]
8. Lipidic spherulites: formulation optimisation by paired optical and cryoelectron microscopy.
Crauste-Manciet S; Larquet E; Khawand K; Bessodes M; Chabot GG; Brossard D; Mignet N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1088-94. PubMed ID: 23523544
[TBL] [Abstract][Full Text] [Related]
9. Confocal Raman microscopy to probe content uniformity of a lipid based powder for inhalation: a quality by design approach.
Schoenherr C; Haefele T; Paulus K; Francese G
Eur J Pharm Sci; 2009 Aug; 38(1):47-54. PubMed ID: 19501161
[TBL] [Abstract][Full Text] [Related]
10. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
11. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines.
Goniotaki M; Hatziantoniou S; Dimas K; Wagner M; Demetzos C
J Pharm Pharmacol; 2004 Oct; 56(10):1217-24. PubMed ID: 15482635
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
14. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
17. Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
Touil YS; Auzeil N; Boulinguez F; Saighi H; Regazzetti A; Scherman D; Chabot GG
Biochem Pharmacol; 2011 Dec; 82(11):1731-9. PubMed ID: 21840301
[TBL] [Abstract][Full Text] [Related]
18. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer.
Chen Y; Wu Q; Song L; He T; Li Y; Li L; Su W; Liu L; Qian Z; Gong C
ACS Appl Mater Interfaces; 2015 Jan; 7(1):534-42. PubMed ID: 25495760
[TBL] [Abstract][Full Text] [Related]
20. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.
Gubernator J; Chwastek G; Korycińska M; Stasiuk M; Grynkiewicz G; Lewrick F; Süss R; Kozubek A
J Control Release; 2010 Aug; 146(1):68-75. PubMed ID: 20510316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
